Hikma Pharmaceuticals : , GlaxoSmithKline End Talks Over Egypt, Tunisia Deals

By Adria Calatayud

Hikma Pharmaceuticals PLC said Thursday that talks have ceased over a potential acquisition of GlaxoSmithKline PLC's pharmaceutical and consumer businesses in Egypt and pharmaceutical business in Tunisia.

FTSE 100 pharmaceutical company Hikma said it won't be launching a mandatory tender offer process to acquire shares in GlaxoSmithKline SAE Egypt.

Hikma in January said that it had entered into a preliminary agreement with GSK's Egyptian subsidiary.

Write to Adria Calatayud at [e-mail]

(END) Dow Jones Newswires

03-11-21 0902ET